Tesser, John http://orcid.org/0000-0002-2706-7171
Lin, Iris http://orcid.org/0000-0003-0176-4435
Shiff, Natalie J. http://orcid.org/0000-0002-7410-9709
Chakravarty, Soumya D. http://orcid.org/0000-0001-7957-838X
Schmajuk, Gabriela http://orcid.org/0000-0003-2687-5043
Hammam, Nevin http://orcid.org/0000-0002-7754-5581
Desai, Sheetal http://orcid.org/0000-0002-7180-8387
Funding for this research was provided by:
Janssen Research and Development
Article History
Received: 20 December 2021
Revised: 15 February 2022
Accepted: 22 February 2022
First Online: 21 March 2022
Declarations
:
: A central Institutional Review Board (Western IRB) and the University of California San Francisco IRB have approved procedures for data analyses for this project.
: Because the Rheumatology Informatics System for Effectiveness (RISE) Registry is a federally Qualified Clinical Data Registry, permissions are in place to collect data without patient informed consent for the purpose of disease tracking and quality improvement. The RISE data extraction protocol is Health Insurance Portability and Accountability Act compliant. Any RISE data used for research is analyzed only by American College of Rheumatology-contracted data analytic centers (including University of California San Francisco) and is de-identified and aggregated.
: JT has served on advisory boards/as a consultant for AbbVie, AstraZeneca, Aurinia, Bristol Myers Squibb, Janssen, Eli Lilly, Novartis, Pfizer, and Sanofi-Genzyme; served as a speaker for AbbVie, Amgen, AstraZeneca, Aurinia, Bristol Myers Squibb, Eli Lilly, Genentech, GSK, Janssen, Pfizer, and Sanofi-Genzyme; and received research grants and support from AbbVie, Amgen, AstraZeneca, Aurinia, Biogen, Bristol Myers Squibb, Boehringer Ingelheim, Celgene, CSL Behring, Eli Lilly, Genentech, Gilead, GlaxoSmithKline, Horizon, Janssen, Merck KG, Novartis, Pfizer, R-Pharma, Regeneron, Roche, Sandoz, Scipher, Takeda, Sun Pharma, UCB, Selecta, and Vorso. IL, NS, and SDC are employees of Janssen Scientific Affairs, LLC, and own stock in Johnson & Johnson, of which Janssen Scientific Affairs, LLC, is a wholly owned subsidiary of (IL, NS, SDC), AbbVie (NS), and Gilead (NS). GS is funded by AHRQ and VA HSR&D. NH has no disclosures. SD served on speakers bureaus for AstraZeneca, Aurinia, GlaxoSmithKline, and Janssen.